RespireRx Pharmaceuticals Inc.
RSPI · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,103 | -$3,145 | -$4,301 | -$2,115 |
| Dep. & Amort. | $0 | $552,787,000 | $374,080,000 | $215,575,000 |
| Deferred Tax | $0 | -$552,787,000 | -$374,080,000 | -$994,982,000 |
| Stock-Based Comp. | $0 | $59 | $384 | $779,407,000 |
| Change in WC | $1,468 | $1,654 | $2,541 | $1,437 |
| Other Non-Cash | $490 | $476 | $863 | $190 |
| Operating Cash Flow | -$144 | -$956 | -$513 | -$488 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $25 | $839 | $334 | $501 |
| Stock Issued | $0 | $117 | $163 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $118 | $0 | $0 | -$30 |
| Financing Cash Flow | $143 | $957 | $497 | $471 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1 | $1 | -$16 | -$17 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $1 | $17 | $33 |
| End Cash | $0 | $1 | $1 | $17 |
| Free Cash Flow | -$144 | -$956 | -$513 | -$488 |